Friend leukemia integration 1 overexpression decreases endometrial receptivity and induces embryo implantation failure by promoting PART1 transcription in the endometrial epithelial cells

• Published in: PeerJ (San Francisco, CA) Vol. 11; p. e16105
• Main Authors: Zhang, Yile, Yin, Beining, Li, Sichen, Cui, Yueyue, Liu, Jianrong
• Format: Journal Article
• Language: English
• Published: United States PeerJ. Ltd 26.09.2023; PeerJ Inc
• Subjects: Analysis; Animals; Bioinformatics; Cell Biology; Chromatin; Chromatin - genetics; Chromatin - metabolism; Embryo; Embryo Implantation - genetics; Embryonic development; Endometrial receptivity; Endometrium - metabolism; Endometrium - pathology; Epithelial Cells; Ethylenediaminetetraacetic acid; Female; FLI1; Genetic transcription; Gynecology and Obstetrics; Health aspects; Histology; Humans; Leukemia; Mice; Molecular Biology; PART1; Pregnancy; Pregnant women; Proto-Oncogene Protein c-fli-1 - metabolism; Recurrent implantation failure (RIF); RNA; RNA sequencing; RNA, Long Noncoding - genetics; RNA, Long Noncoding - metabolism; Single cell chromatin accessibility sequencing (scATAC-seq); Stem cells; Technology application; Japan; China; PART1; Single cell chromatin accessibility sequencing (scATAC-seq); Endometrial receptivity; FLI1; Recurrent implantation failure (RIF)
• ISSN: 2167-8359; 2167-8359
• DOI: 10.7717/peerj.16105

fertilization-embryo transfer (IVF-ET) is a crucial assisted reproductive technology for treating infertility. However, recurrent implantation failure (RIF), a significant challenge in IVF-ET success, remains unresolved. This study aimed to explore the role and mechanism of FLI1 in endometrial receptivity and RIF. Differential endometrial cell proportions between patients with RIF and control subjects were assessed using single-cell RNA sequencing (scRNA-seq) analysis. The chromatin accessibility of FLI1 in the luteal endometrial tissue of patients with RIF and control subjects was examined using the single-cell assay for transposase-accessible chromatin sequencing (scATAC-seq). FLI1 mRNA and protein levels were gauged by quantitative real-time polymerase chain reaction (qRT-PCR) and western blotting. Cell viability and migration were examined via cell counting kit (CCK)-8 and scratch healing assays. Epithelial-mesenchymal transition markers were analyzed using western blotting. Mechanisms underlying FLI1's regulation of PART1 transcription and expression in endometrial epithelial cells were explored using chromatin immunoprecipitation and dual-luciferase reporter assays. Adeno-associated virus (AAV) carrying epithelial cell-specific FLI1/PART1 overexpression sequences was uterinely injected in mice to assess FLI1/PART1 effects. scRNA-seq revealed diminished endometrial epithelial cell proportions in RIF patients. Meanwhile, scATAC-seq indicated enhanced chromatin accessibility of FLI1 in these cells. FLI1 exhibited specific expression in RIF patients' endometrial epithelial cells. Specific FLI1 overexpression inhibited embryo implantation, while knockdown enhanced it. Pregnant mice injected with AAV encoding FLI1 overexpression had significantly lower implantation than AAV-negative controls. FLI1 binding to PART1 promoter heightened PART1 transcription and expression in endometrial epithelial cells. Rescue experiments illustrated FLI1's role in embryo implantation by boosting PART1 expression. PART1 was notably elevated in RIF patients' luteal endometrial tissue and non-receptive endometrial epithelial cells (HEC-1-A). Specific PART1 overexpression dampened embryo implantation, whereas knockdown promoted it. Pregnant mice injected with AAV encoding PART1 had lower implantation than negative controls. PART1 knockdown mitigated FLI1's inhibitory impact on HEC-1-A cell viability and migration. FLI1 overexpression in the endometrial epithelial cells of patients with RIF inhibited embryo implantation by binding to the promoter region to promote expression. These findings can aid in the development of novel therapeutic targets for RIF.